Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01641445 · ClinicalTrials.gov registry record · Phase 1

Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms

A Phase 1 study, sponsored by Brown University.

Completed
Registry status
Phase 1
Development phase
82
Enrollment target

NCT01641445 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01641445, a Phase 1 study, has completed, sponsored by Brown University.

COMPLETED
Registry status
Phase 1
Development phase
82 participants
Enrollment target

Study Summary

This study will help to determine whether the medication, topiramate, reduces alcohol use among adolescents with alcohol dependence. It will also help answer the question, "How does topiramate reduce drinking in teenagers?" Understanding how topiramate may reduce drinking in adolescents would allow for a more targeted pharmacotherapeutic approach to treatment and help to identify additional medications that may hold promise for improving treatment outcomes for youth.

Interventions

  • DRUG Placebo
  • DRUG Topiramate

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2012-07
Est. Completion 2017-04-12
Phase Phase 1

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT01641445

The ClinicalTrials.gov registry entry for NCT01641445 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01641445 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01641445 about?

NCT01641445 is a clinical study titled "Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms". This study will help to determine whether the medication, topiramate, reduces alcohol use among adolescents with alcohol dependence. It will also help answer the question, "How does topiramate reduce drinking in teenagers?" Understanding how topiramate may reduce drinking in adolescents would allow ...

What is the current status of trial NCT01641445?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 82 participants. The study started on 2012-07. Estimated completion is 2017-04-12.

What interventions are being tested in trial NCT01641445?

The interventions under investigation include: Placebo (DRUG), Topiramate (DRUG).

Who is sponsoring clinical trial NCT01641445?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.